Usefulness and validation of the survival post TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis

Fabrizio D'Ascenzo, Davide Capodanno, Giuseppe Tarantini, Freek Nijhoff, Cristina Ciuca, Marco Luciano Rossi, Nedy Brambilla, Marco Barbanti, Massimo Napodano, Pieter Stella, Francesco Saia, Giuseppe Ferrante, Corrado Tamburino, Valeria Gasparetto, Pierfrancesco Agostoni, Antonio Marzocchi, Patrizia Presbitero, Francesco Bedogni, Enrico Cerrato, Pierluigi OmedèFederico Conrotto, Stefano Salizzoni, Giuseppe Biondi Zoccai, Sebastiano Marra, Mauro Rinaldi, Fiorenzo Gaita, Maurizio D'Amico, Claudio Moretti

Research output: Contribution to journalArticle

Abstract

Surgical risk scores fail to accurately predict mortality after transcatheter aortic valve implantation (TAVI). The aimof this study was to develop and validate a dedicated risk score for accurate estimation of mortality risk in these patients. All consecutive patients who underwent TAVI at 6 international institutionswere enrolled. Predictors for 1-year all-causemortality were identified by means of Cox multivariate analysis and incorporated in a prediction score. Accuracy of the score was derived and externally validated for 30-day and 1-year mortality. The net classification improvement comparedwith the Society ofThoracic Surgeons (STS) scorewas appraised. A total of 1,064 patients constituted the derivation cohort and 180 patients constituted the external validation cohort. A total of 165 patients (15%) died at 1-year follow-up. Previous stroke (odds ratio [OR] 1.80, 1.4 to 3), inverse of renal clearance (OR 8, 6 to 14), and systolic pulmonary arterial pressure ≥50mmHg (OR 2.10, 1.5 to 3) were independently related to 1-year mortality. Area under the curve (AUC) of the survival post TAVI (STT) for 1-year mortality was 0.68 (0.62 to 0.71). At 30 days, 65 patients (7%) had died and the AUC for the STT at this time point was 0.66 (0.64 to 0.75). In the external validation cohorts, theAUC of the STT were 0.66 (0.56 to 0.7) for 30-day and 0.67 (0.62 to 0.71) for 1-year mortality. Net reclassification improvement for STT compared with STS was 31% (p

Original languageEnglish
Pages (from-to)1867-1874
Number of pages8
JournalThe American Journal of Cardiology
Volume114
Issue number12
DOIs
Publication statusPublished - 2014

Fingerprint

Aortic Valve Stenosis
Survival
Mortality
Odds Ratio
Area Under Curve
Transcatheter Aortic Valve Replacement
Arterial Pressure
Multivariate Analysis
Stroke
Kidney
Lung

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Usefulness and validation of the survival post TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis. / D'Ascenzo, Fabrizio; Capodanno, Davide; Tarantini, Giuseppe; Nijhoff, Freek; Ciuca, Cristina; Rossi, Marco Luciano; Brambilla, Nedy; Barbanti, Marco; Napodano, Massimo; Stella, Pieter; Saia, Francesco; Ferrante, Giuseppe; Tamburino, Corrado; Gasparetto, Valeria; Agostoni, Pierfrancesco; Marzocchi, Antonio; Presbitero, Patrizia; Bedogni, Francesco; Cerrato, Enrico; Omedè, Pierluigi; Conrotto, Federico; Salizzoni, Stefano; Zoccai, Giuseppe Biondi; Marra, Sebastiano; Rinaldi, Mauro; Gaita, Fiorenzo; D'Amico, Maurizio; Moretti, Claudio.

In: The American Journal of Cardiology, Vol. 114, No. 12, 2014, p. 1867-1874.

Research output: Contribution to journalArticle

D'Ascenzo, F, Capodanno, D, Tarantini, G, Nijhoff, F, Ciuca, C, Rossi, ML, Brambilla, N, Barbanti, M, Napodano, M, Stella, P, Saia, F, Ferrante, G, Tamburino, C, Gasparetto, V, Agostoni, P, Marzocchi, A, Presbitero, P, Bedogni, F, Cerrato, E, Omedè, P, Conrotto, F, Salizzoni, S, Zoccai, GB, Marra, S, Rinaldi, M, Gaita, F, D'Amico, M & Moretti, C 2014, 'Usefulness and validation of the survival post TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis', The American Journal of Cardiology, vol. 114, no. 12, pp. 1867-1874. https://doi.org/10.1016/j.amjcard.2014.09.031
D'Ascenzo, Fabrizio ; Capodanno, Davide ; Tarantini, Giuseppe ; Nijhoff, Freek ; Ciuca, Cristina ; Rossi, Marco Luciano ; Brambilla, Nedy ; Barbanti, Marco ; Napodano, Massimo ; Stella, Pieter ; Saia, Francesco ; Ferrante, Giuseppe ; Tamburino, Corrado ; Gasparetto, Valeria ; Agostoni, Pierfrancesco ; Marzocchi, Antonio ; Presbitero, Patrizia ; Bedogni, Francesco ; Cerrato, Enrico ; Omedè, Pierluigi ; Conrotto, Federico ; Salizzoni, Stefano ; Zoccai, Giuseppe Biondi ; Marra, Sebastiano ; Rinaldi, Mauro ; Gaita, Fiorenzo ; D'Amico, Maurizio ; Moretti, Claudio. / Usefulness and validation of the survival post TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis. In: The American Journal of Cardiology. 2014 ; Vol. 114, No. 12. pp. 1867-1874.
@article{0114890cf10346f6860f0ebc0fcaa467,
title = "Usefulness and validation of the survival post TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis",
abstract = "Surgical risk scores fail to accurately predict mortality after transcatheter aortic valve implantation (TAVI). The aimof this study was to develop and validate a dedicated risk score for accurate estimation of mortality risk in these patients. All consecutive patients who underwent TAVI at 6 international institutionswere enrolled. Predictors for 1-year all-causemortality were identified by means of Cox multivariate analysis and incorporated in a prediction score. Accuracy of the score was derived and externally validated for 30-day and 1-year mortality. The net classification improvement comparedwith the Society ofThoracic Surgeons (STS) scorewas appraised. A total of 1,064 patients constituted the derivation cohort and 180 patients constituted the external validation cohort. A total of 165 patients (15{\%}) died at 1-year follow-up. Previous stroke (odds ratio [OR] 1.80, 1.4 to 3), inverse of renal clearance (OR 8, 6 to 14), and systolic pulmonary arterial pressure ≥50mmHg (OR 2.10, 1.5 to 3) were independently related to 1-year mortality. Area under the curve (AUC) of the survival post TAVI (STT) for 1-year mortality was 0.68 (0.62 to 0.71). At 30 days, 65 patients (7{\%}) had died and the AUC for the STT at this time point was 0.66 (0.64 to 0.75). In the external validation cohorts, theAUC of the STT were 0.66 (0.56 to 0.7) for 30-day and 0.67 (0.62 to 0.71) for 1-year mortality. Net reclassification improvement for STT compared with STS was 31{\%} (p",
author = "Fabrizio D'Ascenzo and Davide Capodanno and Giuseppe Tarantini and Freek Nijhoff and Cristina Ciuca and Rossi, {Marco Luciano} and Nedy Brambilla and Marco Barbanti and Massimo Napodano and Pieter Stella and Francesco Saia and Giuseppe Ferrante and Corrado Tamburino and Valeria Gasparetto and Pierfrancesco Agostoni and Antonio Marzocchi and Patrizia Presbitero and Francesco Bedogni and Enrico Cerrato and Pierluigi Omed{\`e} and Federico Conrotto and Stefano Salizzoni and Zoccai, {Giuseppe Biondi} and Sebastiano Marra and Mauro Rinaldi and Fiorenzo Gaita and Maurizio D'Amico and Claudio Moretti",
year = "2014",
doi = "10.1016/j.amjcard.2014.09.031",
language = "English",
volume = "114",
pages = "1867--1874",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Usefulness and validation of the survival post TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis

AU - D'Ascenzo, Fabrizio

AU - Capodanno, Davide

AU - Tarantini, Giuseppe

AU - Nijhoff, Freek

AU - Ciuca, Cristina

AU - Rossi, Marco Luciano

AU - Brambilla, Nedy

AU - Barbanti, Marco

AU - Napodano, Massimo

AU - Stella, Pieter

AU - Saia, Francesco

AU - Ferrante, Giuseppe

AU - Tamburino, Corrado

AU - Gasparetto, Valeria

AU - Agostoni, Pierfrancesco

AU - Marzocchi, Antonio

AU - Presbitero, Patrizia

AU - Bedogni, Francesco

AU - Cerrato, Enrico

AU - Omedè, Pierluigi

AU - Conrotto, Federico

AU - Salizzoni, Stefano

AU - Zoccai, Giuseppe Biondi

AU - Marra, Sebastiano

AU - Rinaldi, Mauro

AU - Gaita, Fiorenzo

AU - D'Amico, Maurizio

AU - Moretti, Claudio

PY - 2014

Y1 - 2014

N2 - Surgical risk scores fail to accurately predict mortality after transcatheter aortic valve implantation (TAVI). The aimof this study was to develop and validate a dedicated risk score for accurate estimation of mortality risk in these patients. All consecutive patients who underwent TAVI at 6 international institutionswere enrolled. Predictors for 1-year all-causemortality were identified by means of Cox multivariate analysis and incorporated in a prediction score. Accuracy of the score was derived and externally validated for 30-day and 1-year mortality. The net classification improvement comparedwith the Society ofThoracic Surgeons (STS) scorewas appraised. A total of 1,064 patients constituted the derivation cohort and 180 patients constituted the external validation cohort. A total of 165 patients (15%) died at 1-year follow-up. Previous stroke (odds ratio [OR] 1.80, 1.4 to 3), inverse of renal clearance (OR 8, 6 to 14), and systolic pulmonary arterial pressure ≥50mmHg (OR 2.10, 1.5 to 3) were independently related to 1-year mortality. Area under the curve (AUC) of the survival post TAVI (STT) for 1-year mortality was 0.68 (0.62 to 0.71). At 30 days, 65 patients (7%) had died and the AUC for the STT at this time point was 0.66 (0.64 to 0.75). In the external validation cohorts, theAUC of the STT were 0.66 (0.56 to 0.7) for 30-day and 0.67 (0.62 to 0.71) for 1-year mortality. Net reclassification improvement for STT compared with STS was 31% (p

AB - Surgical risk scores fail to accurately predict mortality after transcatheter aortic valve implantation (TAVI). The aimof this study was to develop and validate a dedicated risk score for accurate estimation of mortality risk in these patients. All consecutive patients who underwent TAVI at 6 international institutionswere enrolled. Predictors for 1-year all-causemortality were identified by means of Cox multivariate analysis and incorporated in a prediction score. Accuracy of the score was derived and externally validated for 30-day and 1-year mortality. The net classification improvement comparedwith the Society ofThoracic Surgeons (STS) scorewas appraised. A total of 1,064 patients constituted the derivation cohort and 180 patients constituted the external validation cohort. A total of 165 patients (15%) died at 1-year follow-up. Previous stroke (odds ratio [OR] 1.80, 1.4 to 3), inverse of renal clearance (OR 8, 6 to 14), and systolic pulmonary arterial pressure ≥50mmHg (OR 2.10, 1.5 to 3) were independently related to 1-year mortality. Area under the curve (AUC) of the survival post TAVI (STT) for 1-year mortality was 0.68 (0.62 to 0.71). At 30 days, 65 patients (7%) had died and the AUC for the STT at this time point was 0.66 (0.64 to 0.75). In the external validation cohorts, theAUC of the STT were 0.66 (0.56 to 0.7) for 30-day and 0.67 (0.62 to 0.71) for 1-year mortality. Net reclassification improvement for STT compared with STS was 31% (p

UR - http://www.scopus.com/inward/record.url?scp=84922259485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922259485&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2014.09.031

DO - 10.1016/j.amjcard.2014.09.031

M3 - Article

C2 - 25438915

AN - SCOPUS:84922259485

VL - 114

SP - 1867

EP - 1874

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12

ER -